Champions Oncology

Champions Oncology is a publicly traded oncology-focused CRO and translational research company that provides preclinical and clinical specialty testing services to biopharma customers. Its core assets include a large bank of patient-derived xenograft models, ex vivo and in vivo pharmacology platforms, biomarker testing capabilities, and the Lumin data platform built around multi-omic and functional oncology datasets. The company supports oncology drug discovery and development across a wide range of therapeutic modalities, including radiopharmaceuticals, through fee-for-service research and data-enabled offerings. Champions also operates GCLP-compliant specialty testing capabilities and has been expanding its data-centric and AI-enabled translational oncology strategy. The business is commercial-stage and generates revenue primarily from oncology research services rather than from an internal therapeutic pipeline.